Guide for Authors

Guide for Authors

Epilepsy & Behavior has been, and still is, the fastest-growing international journal since its launch nearly six years ago. Epilepsy & Behavior is uniquely devoted to the rapid dissemination of the most current information available on the behavioral aspects of seizures and epilepsy.

Epilepsy & Behavior presents original peer-reviewed articles based on laboratory and clinical research. Topics are drawn from a variety of fields, including clinical neurology, neurosurgery, neuropsychiatry, neuropsychology, neurophysiology, neuropharmacology, and neuroimaging.

Epilepsy & Behavior publishes papers on the study of:

Localization of ictal and postictal behaviors
Neuroendocrine aspects of epilepsy
Psychiatric and psychosocial aspects of epilepsy
Behavioral aspects of epilepsy surgery
Cognitive and affective effects of seizure treatment
Functional imaging
Animal models


This timely resource also includes comprehensive reviews written by the world's experts, pertinent editorials, and book reviews. Epilepsy & Behavior reviews are solicited by the Editor-in-Chief.

Submission of Manuscripts



It is a condition of publication that all manuscripts must be written in clear and grammatical English and be submitted to the Epilepsy & Behavior web site at http://ees.elsevier.com/eb.. Each manuscript must also be accompanied by a cover letter outlining the basic findings of the paper and their significance. Authors should suggest at least three competent reviewers in their field and may also suggest individuals whom they wish to have excluded from the review process. Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out. As part of the submission process your paper may be screened for English language usage and conformity to the guide for authors before it reaches the review stage. This is to ensure the journal's high standards are maintained and the review process is kept to a minimum. Passing this check is not a guarantee that your submission will subsequently proceed to the peer review process, which is a decision to be made at the sole discretion of the journal editor.

Copyright
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement'' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Oxford, UK: phone (+44) 1865 843830, fax (+44) 1865 853333, e-mail permissions@elsevier.com. Requests may also be completed online via the Elsevier homepage ( http://www.elsevier.com/locate/permissions).

US National Institutes of Health (NIH) voluntary posting ("Public Access") policy.
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access Policy"; see http://www.nih.gov/about/publicaccess/index.htm) by posting the author's peer-reviewed manuscript directly to PubMed Central on request from the author, 12 months after formal publication. Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com) that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is prohibited.

Language polishing
International Science Editing and Asia Science Editing can provide English language and copyediting services to authors who want to publish in scientific, technical and medical journals and need assistance before they submit their article or before it is accepted for publication. Authors can contact these services directly: International Science Editing ( http://www.internationalscienceediting.com) and Asia Science Editing ( http://www.asiascienceediting.com ) or, for more information about language editing services, authors may contact authorsupport@elsevier.com who will be happy to deal with any questions. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please refer to our terms and conditions ( http://authors.elsevier.com/terms_and_conditions.html ).

Preparation of Manuscripts
Pages should be numbered consecutively and organized as follows:

The Title Page (p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers). Please note that proprietary names for drugs should not be used in the article title.

The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 150 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.

The Introduction should be as concise as possible, without subheadings.

Methods should be sufficiently detailed to enable the study to be reproduced.

Results and Discussion should be separate and may be organized into subheadings.

Acknowledgments should be brief and should precede the references.

References should be cited in the text by numbers in brackets, in order of appearance and follow the Vancouver Style ( http://www.library.uwa.edu.au/guides/citingsources/vancouver.html ). Only articles that have been published or are in press should be included in the references. Authors are responsible for the accuracy of references. Unpublished results or personal communications should be cited as such in the text. Please note the following examples:

[1] Hermann BP, Seidenberg M, Bell B, Woodard A, Rutecki P, Sheth R. Comorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of life. Epilepsy Behav 2000;1:184-90.

[2] Paxinos G, Ashwell KWS, Tork I. Atlas of the developing rat nervous system. 2nd ed. San Diego: Academic Press; 1994.

[3] Shafer PO, Salmanson E. Psychosocial aspects of epilepsy. In: Schachter SC, Schomer DL, editors. The comprehensive evaluation and treatment of epilepsy: a practical guide. San Diego: Academic Press; 1997. p. 91-109.

Figures. Number figures consecutively with Arabic numerals. Please visit our Web site at http://authors.elsevier.com/artwork for detailed instructions on preparing electronic artwork.

One color figure will be reproduced free of charge at the discretion of the reviewers and the Editor-in-Chief. Additional color figures in print will be charged to the contributors. However, if together with your accepted article you submit usable color figures, then Elsevier will ensure, at no additional charge, that these figures will appear in color on the web (e.g., ScienceDirect and other sites) regardless of whether these illustrations are reproduced in color in the printed version. For further information on the preparation of electronic artwork, please see http://authors.elsevier.com/artwork.

Please note: Because of technical complications that can arise in converting color figures to "gray scale" (for the printed version should you not opt for color in print), please submit in addition usable black-and-white files corresponding to all the color illustrations.

Color figures for exclusive use as cover illustration may be submitted by authors who are also submitting a manuscript for consideration. These figures should relate to the manuscript being submitted as well as the larger scope and focus of Epilepsy & Behavior.

Figure legends should be submitted on a separate page. Figure legends should be concise descriptions of the illustration. Detailed information pertaining to the figure should be included within text, with the appropriate reference to the figure number.

Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Give each table a short descriptive title typed directly above it, with essential footnotes below.

Ethics
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable. The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.

Preparation of Supplementary Material
Elsevier now accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer additional possibilities for publishing supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect ( http://www.sciencedirect.com ). To ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. Please note, however, that supplementary material will not appear in the printed journal. For more detailed instructions, please contact the Editorial Office at eb@elsevier.com.

Proofs
One set of page proofs in PDF format will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post). Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 available free from http://www.adobe.com/products/acrobat/readstep2.html . Instructions on how to annotate PDF files will accompany the proofs. The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win . If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.

Author enquiries
For enquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage at http://www.elsevier.com/locate/yebeh. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed, as well as copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication.

Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 50 free paper offprints. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Additional reprints may be ordered on the reprint order form which will accompany the proofs sent to the author. Reprints may also be obtained after publication of the paper at a somewhat higher cost.

Online Publication
Your article will appear on Elsevier's online journal database ScienceDirect as an "Article in Press" within approximately 4-6 weeks of acceptance. Articles in Press can be viewed at http://www.sciencedirect.com. An Article in Press may be cited prior to its publication in an issue of the journal by means of its unique digital object identifier (DOI) number, which does not change throughout the publication process. At the same time, Medline/PubMed will list the article in its database, linking to the full text of the paper in ScienceDirect. Medline/PubMed is freely accessible to researchers around the world.

Sponsored Articles
Epilepsy & Behavior offers authors or their institutions the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please visit http://www.elsevier.com/wps/find/authorshome.authors/yebeh

Disclaimer
Whilst every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement appears in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the sole responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editorial board and editors and their respective employees, officers and agents accept no responsibility or liability whatsoever for the consequences of any inaccurate or misleading data, opinion or statement.